Friday 6 November 2026 Export BMY’s income statement to Excel — free account

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024.

Revenue: +6.93%
EPS: −2.02%
Free cash flow: −36.0%
Total debt: −12.5%

Quarter to September 2026, against a year earlier

62.43 0.70 −1.11%

Follow BMY

Alert me

Market cap: $129.0B
P/E: 14.0×
Fwd P/E: 11.9×
Dividend yield: 3.99%
F-score: 8/9
Altman Z: 2.14
Beneish M: −2.69
Dividend safety: 63/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Bristol Myers Squibb Company (BMY) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Bristol Myers Squibb Company (BMY) trades at a P/S ratio of 2.6×. Over the past ten years it has ranged from 1.7× (July 2024) to 7.3× (June 2016); the current reading is higher than 24% of that period. That is below the Drug Manufacturers General industry median of 3.5× and below the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BMY/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Bristol Myers Squibb Company P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BMY/metrics/ps-ratio">Bristol Myers Squibb Company (BMY) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	2.3×	(4.09%)
FY2024	2.4×	(2.14%)
FY2023	2.4×	(27.26%)
FY2022	3.3×	11.69%
FY2021	3.0×	(9.37%)
FY2020	3.3×	(21.30%)
FY2019	4.2×	11.26%
FY2018	3.8×	(22.50%)
FY2017	4.9×	(5.07%)
FY2016	5.1×	(26.15%)

Period	P/S ratio	Change
Sep 2026	2.5×	6.52%
Jun 2026	2.4×	(6.17%)
Mar 2026	2.5×	11.99%
Dec 2025	2.3×	19.09%
43 more quarters	Free account

Against its own ten years

Low 1.7× High 7.3×

Ten-year median 3.4×

Current reading's percentile 26

Company	P/S ratio
SNY Sanofi compare	1.9×
GSK GSK PLC Sponsored ADR compare	2.2×
BMY Bristol Myers Squibb Company	2.6×
PFE Pfizer Inc. compare	2.7×
NVO Novo Nordisk A/S compare	3.5×
AZN AstraZeneca PLC compare	4.7×
NVS Novartis AG compare	5.4×
AMGN Amgen Inc. compare	6.4×
GILD Gilead Sciences, Inc. compare	6.7×
Drug Manufacturers General industry median	3.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Bristol Myers Squibb Company (BMY) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on BMY

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on BMY

Stockrow Weekly